Nivedita Mookerji And Sohini Das

Stories by Nivedita Mookerji And Sohini Das

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.

USAID Funding To India Declines Amid Trump's Freeze

USAID Funding To India Declines Amid Trump's Freeze

Rediff.com   13 Feb 2025

'If the Bill and Melinda Gates Foundation cuts funds, there could be more impact.'

Highest Selling New Drug In India Is...

Highest Selling New Drug In India Is...

Rediff.com   11 Feb 2025

Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com   10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

'Prime Minister Modi Has Been Fiscally Conscious'

'Prime Minister Modi Has Been Fiscally Conscious'

Rediff.com   5 Feb 2025

'Spend, but create assets, spend but make sure that people benefit from it.' 'This has been a beautiful guiding principle. And I think as a finance minister I owe so much to the prime minister for keeping this path clear before us.'

'Budget's Main Objective Was To Honour Taxpayers'

'Budget's Main Objective Was To Honour Taxpayers'

Rediff.com   5 Feb 2025

'Our attempt to honour the taxpayer has been since 2014 and more actively since 2019-2020 onwards.'

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com   3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

Trump's Tariff War: India Waits, Watches

Trump's Tariff War: India Waits, Watches

Rediff.com   3 Feb 2025

'We have to be prepared for the larger disruption that is likely to take place.'

GBS Disease: 16 Patients On Ventilator

GBS Disease: 16 Patients On Ventilator

Rediff.com   27 Jan 2025

Water samples from different parts of Pune have been sent to the public health laboratory for chemical and biological analysis.

New Tata EVs will run 500 km on single charge

New Tata EVs will run 500 km on single charge

Rediff.com   13 Jan 2025

As battery prices drop, early customers of Tata Motors, which was the first mover in the passenger EV market, could feel let down.

How is Tata Motors gearing up to face competition?

How is Tata Motors gearing up to face competition?

Rediff.com   8 Jan 2025

Why is Shailesh Chandra, managing director of Tata Motors Passenger Vehicles and Tata Passenger Electric Mobility, not worried about the competition?

Tata Punch Knocks Out Maruti!

Tata Punch Knocks Out Maruti!

Rediff.com   7 Jan 2025

While Maruti held the top spot for four decades, the Ambassador was the best-selling car in post-Independence India for three decades.

Honda-Nissan Merger: What About India?

Honda-Nissan Merger: What About India?

Rediff.com   24 Dec 2024

Two Japanese auto giants, Honda and Nissan, are moving towards a potential merger, but it remains unclear how their Indian operations will be immediately impacted.

'India Not tougher Than Other Markets'

'India Not tougher Than Other Markets'

Rediff.com   23 Dec 2024

'Regulatory challenges exist everywhere. What we look for is regulatory stability over time.'

This is one of the largest health-care deals in India

This is one of the largest health-care deals in India

Rediff.com   13 Dec 2024

'Along with Blackstone, we would be keen to look at opportunities in the North.'